%0 Journal Article %T Multimodal treatments for advanced prostate cancer %A Isaac Y. Kim %A Izak Faiena %A Thomas L. Jang %J Archive of "Oncotarget". %D 2019 %R 10.18632/oncotarget.26525 %X In 2018, an estimated 164,000 men in the United States will be newly diagnosed with prostate cancer. Among these men, at least 10% will present with locally or regionally advanced disease. In contrast to men with clinically localized prostate cancer, where 5-year relative survival rates approach 100%, men with locally advanced (T3-T4 N0 M0) or regionally advanced (T3-T4 N1 M0) prostate cancer are at high risk of death from their disease [1] %K prostate cancer %K radiation %K surgery %K survival %K combined modality therapy %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349456/